Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Reardon

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Hematology/Oncology|June 23, 2000
Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research HospitalA W Walter, A Gajjar, D A Reardon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Pediatric choroid plexus neoplasmsE Chow, D A Reardon, A B Shah, et al.
Pediatric Neurosurgery|March 9, 2000
Malignant evolution of choroid plexus papillomaE Chow, J J Jenkins, P C Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumorsA Gajjar, M Fouladi, A W Walter, et al.
Pediatric Neurosurgery|October 2, 1998
Bithalamic involvement predicts poor outcome among children with thalamic glial tumorsD A Reardon, A Gajjar, R A Sanford, et al.
British Journal of Cancer|November 19, 2009
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyD A Reardon, A Desjardins, J J Vredenburgh, et al.
Cancer Research|October 27, 1997
Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridizationD A Reardon, E Michalkiewicz, J M Boyett, et al.
British Journal of Cancer|November 12, 2009
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastomaD A Reardon, G Dresemann, S Taillibert, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
The Lancet. Oncology|April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomasM J van den Bent, J S Wefel, D Schiff, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|June 23, 2000
Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research HospitalA W Walter, A Gajjar, D A Reardon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Pediatric choroid plexus neoplasmsE Chow, D A Reardon, A B Shah, et al.
Pediatric Neurosurgery|March 9, 2000
Malignant evolution of choroid plexus papillomaE Chow, J J Jenkins, P C Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumorsA Gajjar, M Fouladi, A W Walter, et al.
Pediatric Neurosurgery|October 2, 1998
Bithalamic involvement predicts poor outcome among children with thalamic glial tumorsD A Reardon, A Gajjar, R A Sanford, et al.
British Journal of Cancer|November 19, 2009
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyD A Reardon, A Desjardins, J J Vredenburgh, et al.
Cancer Research|October 27, 1997
Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridizationD A Reardon, E Michalkiewicz, J M Boyett, et al.
British Journal of Cancer|November 12, 2009
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastomaD A Reardon, G Dresemann, S Taillibert, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
The Lancet. Oncology|April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomasM J van den Bent, J S Wefel, D Schiff, et al.
Pageof 3